Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Contract Research Organization (CRO) Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Segmentation

Peripheral Segments

Market Trend Analysis

Market Trend Analysis (continued)

Vendor Ecosystem

Growth Drivers

Growth Restraints

Services and Stakeholders

CRDMO—The Future of Outsourcing

CRDMO—The Future of Outsourcing (continued)

CRDMO Transactions to Support Drug Discovery and Development

CRDMO Transactions to Support Drug Discovery and Development (continued)

Digitization of the Drug Development Value Chain

Digitization of Clinical Research

DCTs—Future Impact on the CRO Industry

Investment Trends—Collaborative Approach for Drug Development

Early- to Late-stage CRO Service Collaboration—Nonclinical

Early- to Late-stage CRO Service Collaboration—Nonclinical (continued)

Early- to Late-stage CRO Service Collaboration—Nonclinical (continued)

Early- to Late-stage CRO Service Collaboration—Clinical

Early- to Late-stage CRO Service Collaboration—Clinical (continued)

Early- to Late-stage CRO Service Collaboration—Clinical (continued)

Technology Partnerships Supporting Industry Convergence

Technology Partnerships Supporting Industry Convergence (continued)

Technology Partnerships Supporting Industry Convergence (continued)

Expanding CRO Expertise through Industry Acquisitions

Expanding CRO Expertise through Industry Acquisitions (continued)

Expanding CRO Expertise through Industry Acquisitions (continued)

Expanding CRO Expertise through Industry Acquisitions (continued)

Expanding CRO Expertise through Industry Acquisitions (continued)

Expanding CRO Expertise through Industry Acquisitions (continued)

Growth Metrics

Forecast Assumptions

Forecast Assumptions (continued)

Revenue Forecast

Revenue Forecast—Clinical vs. Nonclinical

Revenue Forecast Analysis

Revenue Forecast Analysis (continued)

Growth Metrics

Revenue Forecast Assumptions and Methodology

Key Services—Drug Discovery and Preclinical Research,

Nuances of Drug Discovery and Preclinical Development

Pharmaceutical R&D Expenditure

Revenue Forecast

Revenue Forecast by Nonclinical Phases of Development

Revenue Forecast Analysis

Revenue Forecast Analysis (continued)

Revenue Forecast Analysis (continued)

Growth Metrics

Revenue Forecast Assumptions

Revenue Forecast Methodology

Revenue Forecast

Revenue Forecast by Clinical Phases of Development

Percent Revenue Forecast by Clinical Phases of Development

Revenue Forecast Analysis

Revenue Forecast Analysis (continued)

Clinical Trial Split by Therapy Area

Revenue Share Analysis By Region

North America—Key Trends

North America—Revenue Forecast by Clinical Development Phase

North America—Revenue Forecast Analysis

Europe—Key Trends

Europe—Revenue Forecast by Clinical Development Phase

Europe—Revenue Share Analysis

APAC—Key Trends

APAC—Revenue Forecast by Clinical Development Phases

APAC—Revenue Share Analysis

RoW—Key Trends

RoW—Revenue Forecast by Clinical Development Phase

RoW—Revenue Share Analysis

Competitive Environment

Key Competitors

Revenue Share

Revenue Share Analysis

Revenue Share Analysis (continued)

Cost Split by Service Type

Peripheral Services—Analytical Testing Services

Peripheral Services—Clinical Outcomes and Post-market Surveillance

Peripheral Services—Data Capture and Management

Growth Opportunity 1: Agile Partnership Models for Drug Discovery and Preclinical Drug Testing

Growth Opportunity 1: Agile Partnership Models for Drug Discovery and Preclinical Drug Testing (continued)

Growth Opportunity 2: Bioanalytical CRO Partnerships for Customized Testing Solutions for Biologics

Growth Opportunity 2: Bioanalytical CRO Partnerships for Customized Testing Solutions for Biologics (continued)

Growth Opportunity 3: eClinical Solutions for Pharmacovigilance Services

Growth Opportunity 3: eClinical Solutions for Pharmacovigilance Services (continued)

Growth Opportunity 4: AI-enabled Oncology Trial Design, Recruitment, and Execution

Growth Opportunity 4: AI-enabled Oncology Trial Design, Recruitment, and Execution (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer